Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed /Refractory Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05748197
What this trial is testing

ADCLEC.syn1 in People With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Study completedNCT01130662
What this trial is testing

Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University of Kansas 16
Testing effectiveness (Phase 2)Study completedNCT01550224
What this trial is testing

Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia With 11q23-abnormality in Relapse
Steven E. Coutre 23
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT04176393
What this trial is testing

A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
CStone Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Early research (Phase 1)Ended earlyNCT03519984
What this trial is testing

EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlasts 5 Percent or More of Bone Marrow Nucleated CellsMyelodysplastic/Myeloproliferative Neoplasm+8 more
University of Southern California 3
Testing effectiveness (Phase 2)Study completedNCT00763763
What this trial is testing

Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive

Who this might be right for
Leukemia, Lymphocytic, AcutePhiladelphia ChromosomeBlast Crisis+1 more
Assistance Publique - Hôpitaux de Paris 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07749976
What this trial is testing

GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaDiffuse Large B Cell Lymphoma (DLBCL)High Risk Myelodysplastic Syndrome+2 more
Vitruviae 108
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Early research (Phase 1)Not Yet RecruitingNCT07131085
What this trial is testing

QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)

Who this might be right for
MDSAML
Anhui Provincial Hospital 9
Testing effectiveness (Phase 2)Study completedNCT01435343
What this trial is testing

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloblastic Leukemia
PETHEMA Foundation 55
Testing effectiveness (Phase 2)Looking for participantsNCT06424340
What this trial is testing

MB-dNPM1-TCR.1 in Relapsed/Refractory AML

Who this might be right for
Leukemia, Myeloid, Acute
Miltenyi Biomedicine GmbH 29
Early research (Phase 1)Looking for participantsNCT06820268
What this trial is testing

XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
B-cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 168
Early research (Phase 1)Study completedNCT00981240
What this trial is testing

Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes

Who this might be right for
Acute Myelogenous Leukemia
Sanofi 30
Early research (Phase 1)Ended earlyNCT04951778
What this trial is testing

Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 56
Testing effectiveness (Phase 2)Ended earlyNCT00871689
What this trial is testing

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 2
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Next Page